Drugs / 4Plants
last change Sep 2020 re-read 2 minutes ago

4Plants

Developed for
COVID-19
Investigated by
Institute for Research and Development of Medicinal and Food Plants of Guinea

Trials 1 · a red edge is where a trial was stopped

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04501965 Jun → Aug 2020 COVID-19 Institute for Research and Development of Medicinal and Food Plants of Guinea Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 4Plants ClinicalTrials.gov intervention name — accepted as the source's own label NCT04501965
Route Oral “Participants received 4Plants powder in a 3.5g tea bag orally three times daily for 10 days” NCT04501965